In vivo three-dimensional brain imaging with chemiluminescence probes in Alzheimer’s disease models is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0.533. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →HHS | National Institutes of Health
Grant: R01AG055413 R21AG059134 R21AG078749
NIA NIH HHS
Grant: R21 AG078749
NIA NIH HHS
Grant: R01 AG055413
NIA NIH HHS
Grant: R21 AG059134
National Institutes of Health
Grant: 5R01AG055413-05
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease
National Institutes of Health
Grant: 1R21AG059134-01A1
Near infrared Fluorescence Ocular Imaging of Soluble Amyloid Beta Species
National Institutes of Health
Grant: 1R21AG078749-01
Differentiating Abeta40/42 in plaques with small molecule fluorescent probes
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals